iX Biopharma Ltd. said on Mar, 13 2026 that it has issued 652,725 new ordinary shares following the exercise of warrants at 0.06 Singapore dollars per share.

The allotment raises the company’s issued share capital to 1,037,610,044 shares from 1,036,957,319 shares. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on or about Mar, 17 2026.

After this transaction, a cumulative 6,850,599 warrants—11.91% of the total originally issued—have been exercised. There remain 50,658,880 outstanding warrants, each exercisable at 0.06 Singapore dollars and expiring on Jul, 18 2026.

Warrant holders can find exercise instructions at the company’s website.